Browsing Category
Healthcare Industry News
2513 posts
What KORU Medical Systems (NASDAQ: KRMD) leadership transition means for the future of subcutaneous drug delivery
KORU Medical Systems names Adam Kalbermatten CEO as Linda Tharby retires. Discover what the leadership shift means for KRMD growth and infusion therapy markets.
What does Acadia Healthcare’s new board pick and Wall Street advisory team really signal for ACHC shareholders?
Acadia Healthcare (ACHC) appoints Tenet Healthcare CFO veteran Daniel Cancelmi to its board as Khrom Capital pressure grows. Read the full strategic analysis.
AptarGroup partners with Covirix Medical to explore inhalable antivirals for pandemic-potential respiratory viruses
AptarGroup, Inc. and Covirix Medical explore inhalable antivirals targeting pandemic respiratory viruses. Discover the strategy behind the partnership.
Can iSpecimen Inc.’s AI-powered biospecimen matching agent accelerate precision research workflows? (NASDAQ: ISPC)
Discover how iSpecimen Inc.’s new AI biospecimen matching agent could transform research sample sourcing and accelerate precision medicine studies.
Aveanna Healthcare (Nasdaq: AVAH) agrees to acquire Family First Homecare in Pediatric PDN push
Aveanna Healthcare (AVAH) agrees to acquire Family First Homecare, a 27-location pediatric PDN provider. Read what this deal means for AVAH's growth strategy.
Trinity Capital backs Monteris Medical with $35m to scale NeuroBlate brain surgery technology
Trinity Capital Inc. provides $35 million in growth capital to Monteris Medical. Discover how the NeuroBlate system could reshape minimally invasive neurosurgery.
Inside Galderma’s €500m bond deal and what it reveals about the dermatology market’s financial momentum
Galderma raises €500M via a five-year eurobond to refinance IPO debt and strengthen its balance sheet. Discover what this means for GALD investors.
From Eli Lilly to Hims & Hers: what Kathryn Beiser’s move says about the telehealth platform’s ambitions
Hims & Hers Health appoints Kathryn Beiser as Chief Communications Officer. Explore what the move signals about strategy, growth, and investor sentiment.
Galderma share buyback: CHF 232m repurchase follows full exit by EQT, ADIA, and Auba Investment
Galderma repurchases CHF 232M in shares as EQT exits. Discover what the buyback and ownership shift mean for the dermatology company and investors.
What IFF’s Argentina fermentation hub reveals about the next phase of enzyme manufacturing
International Flavors & Fragrances Inc. expands Latin America bioscience operations with enzyme production and application labs. Discover what this means for industrial biotech.